Abstract:Gliomas, and in particular glioblastoma multiforme, are aggressive brain tumors characterized by a poor prognosis and high rates of recurrence. Current treatment strategies are based on open surgery, chemotherapy (temozolomide) and radiotherapy. However, none of these treatments, alone or in combination, are considered effective in managing this devastating disease, resulting in a median survival time of less than 15 months. The efficiency of chemotherapy is mainly compromised by the blood-brain barrier (BBB) that selectively inhibits drugs from infiltrating into the tumor mass. Cancer stem cells (CSCs), with their unique biology and their resistance to both radio- and chemotherapy, compound tumor aggressiveness and increase the chances of treatment failure. Therefore, more effective targeted therapeutic regimens are urgently required. In this article, some well-recognized biological features and biomarkers of this specific subgroup of tumor cells are profiled and new strategies and technologies in nanomedicine that explicitly target CSCs, after circumventing the BBB, are detailed. Major achievements in the development of nanotherapies, such as organic poly(propylene glycol) and poly(ethylene glycol) or inorganic (iron and gold) nanoparticles that can be conjugated to metal ions, liposomes, dendrimers and polymeric micelles, form the main scope of this summary. Moreover, novel biological strategies focused on manipulating gene expression (small interfering RNA and clustered regularly interspaced short palindromic repeats [CRISPR]/CRISPR associated protein 9 [Cas 9] technologies) for cancer therapy are also analyzed. The aim of this review is to analyze the gap between CSC biology and the development of targeted therapies. A better understanding of CSC properties could result in the development of precise nanotherapies to fulfill unmet clinical needs.

Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment

Contemporary strategies in glioblastoma therapy: Recent developments and innovations

Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery

Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy

Targeted Nanotechnology in Glioblastoma Multiforme

Nanomedicines Targeting Glioma Stem Cells

Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment

Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma

Blood-Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges

Potential of Nanocarrier-Associated Approaches for Better Therapeutic Intervention in the Management of Glioblastoma

Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme

Brain-targeted Nano-architectures for Efficient Drug Delivery and Sensitization in Glioblastoma

Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery Perspective

Biomimetic nanoparticle-driven strategies for targeted drug delivery in glioblastoma

Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment

Comprehensive insights into glioblastoma multiforme: drug delivery challenges and multimodal treatment strategies

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma

Advances in nanotechnology for the treatment of GBM

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors

How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature

Nanoradiosensitizers in glioblastoma treatment: recent advances and future perspectives